George Farmer

Stock Analyst at Scotiabank

(4.13)
# 515
Out of 4,412 analysts
30
Total ratings
42.86%
Success rate
22.03%
Average return

19 Stocks

BioMarin Pharmaceutical
Apr 25, 2024
Maintains: Sector Perform
Price Target: $83$85
Current: $82.13
Upside: +3.49%
Sage Therapeutics
Apr 18, 2024
Maintains: Sector Outperform
Price Target: $34$19
Current: $14.18
Upside: +33.99%
Legend Biotech
Apr 17, 2024
Upgrades: Sector Outperform
Price Target: $65
Current: $45.14
Upside: +44.00%
argenx SE
Mar 26, 2024
Maintains: Sector Perform
Price Target: $402$408
Current: $375.29
Upside: +8.72%
Absci
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $4.78
Upside: +171.97%
NewAmsterdam Pharma Company
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $35
Current: $21.66
Upside: +61.59%
Tempest Therapeutics
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.44
Upside: +277.91%
Syndax Pharmaceuticals
Jan 31, 2024
Downgrades: Sector Perform
Price Target: $36$23
Current: $21.28
Upside: +8.08%
Arcellx
Dec 19, 2023
Initiates: Sector Outperform
Price Target: $66
Current: $51.11
Upside: +29.13%
Kura Oncology
Jul 27, 2023
Initiates: Sector Perform
Price Target: $11
Current: $20.06
Upside: -47.66%
Biomea Fusion
Jul 27, 2023
Initiates: Sector Outperform
Price Target: $41
Current: $10.75
Upside: +281.40%
Biogen
Jul 27, 2023
Initiates: Sector Outperform
Price Target: $327
Current: $215.50
Upside: +51.74%
Aura Biosciences
Jul 27, 2023
Initiates: Sector Outperform
Price Target: $23
Current: $7.50
Upside: +206.67%
Moderna
Nov 17, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $111.62
Upside: -
C4 Therapeutics
Oct 27, 2020
Initiates: Outperform
Price Target: n/a
Current: $6.32
Upside: -
Immunic
Jul 20, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.23
Upside: -
Blueprint Medicines
Mar 17, 2020
Upgrades: Outperform
Price Target: n/a
Current: $93.10
Upside: -
Exelixis
Feb 26, 2020
Maintains: Market Perform
Price Target: n/a
Current: $23.73
Upside: -
Incyte
Jan 3, 2020
Maintains: Market Perform
Price Target: n/a
Current: $52.56
Upside: -